GLP-2 TRZ 100mg Peptides
Built for disciplined research, this GLP-2 TRZ preparation reflects a precise approach to peptide integrity and consistency.
The GLP-2 TRZ Lyophilized Vial is a stabilized, laboratory-grade peptide format designed for controlled research applications. Supplied as a lyophilized powder (no flavor, no fillers), it features the GLP-2 TRZ peptide in a total content of 100mg per vial. The presentation supports accurate reconstitution, reliable aliquoting, and measured handling across a range of protocol-driven studies.
- Each vial contains 100mg of GLP-2 TRZ, enabling rigorous investigations into GLP-2 receptor pathways, gut-associated signaling, epithelial barrier dynamics, and related peptide pharmacology under well-defined laboratory conditions.
The lyophilized format is selected for stability and ease of storage, allowing researchers to reconstitute with an appropriate sterile diluent according to their lab’s standard operating procedures. When handled with care, the formulation supports clear solutions and predictable performance metrics, aiding reproducibility and documentation. Its unadulterated composition keeps the focus on the peptide itself, providing a dependable foundation for dose-ranging work, method development, and exploratory study designs.
Every vial is prepared with attention to clean manufacturing and careful handling. From controlled production to secure packaging, the objective is consistent peptide quality that aligns with methodical research workflows. Each lot is verified through independent analytical testing to confirm identity and assess purity, with batch-level documentation available upon request. Cold-chain stewardship and prudent storage practices help preserve integrity from our facility to your lab.
Why Better Molecule
- USA-based quality – Manufactured and fulfilled in the United States with a strict emphasis on process control.
- Analytically verified – Third-party testing supports identity and purity for reliable, documented results.
- Clean presentation – Lyophilized powder with no unnecessary additives for straightforward reconstitution and measurement.
- Research-first position – Supplied for laboratory applications where traceability, clarity, and consistency matter.
For laboratory research use only. Not for human consumption or therapeutic use. Handle using appropriate laboratory practices and store according to your institution’s guidelines.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-2 TRZ?
GLP-2 TRZ appears to be a supplier-specific name for a GLP-2-oriented research compound or analog. Because the 'TRZ' suffix is not a universal scientific naming standard, the exact structure should be confirmed from the product specification or COA. Conservative site copy should therefore describe it as a GLP-2-pathway laboratory compound.
What is GLP-2 TRZ typically studied for?
GLP-2-related compounds are usually studied for intestinal growth, mucosal integrity, nutrient-absorption physiology, and gut-repair signaling. The safest FAQ wording is to explain those GLP-2 research themes while noting that the exact behavior of this product depends on the specific analog being sold.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Better Molecule are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
